The addition of Japanese, Thai and traditional Chinese helps improve access to care
Denver
,
December 13, 2023
/PRNewswire/ — InverMedica, the global digital health leader specializing in AI-powered solutions for symptom analysis and patient triage, today announced a significant expansion of its linguistic offerings. With the addition of Japanese, Thai, and Traditional Chinese language support to its medical guidance platform, Infermedica expands its capabilities to a total of 24 languages, underscoring its commitment to enhancing healthcare access worldwide, reducing incorrect medical assessments, and simplifying healthcare delivery costs. Quality care.
With these new language additions, Infermedica aims to improve access to healthcare, especially in
East Asia
In collaboration with partners such as international health insurance provider
Allianz Care
. Expanding into these languages is a strategic move to expand the company’s reach, especially in regions where language barriers significantly impact access to healthcare. Recent statistics show that in the United States alone, two-thirds of people with limited English proficiency report barriers to accessing health care due to language problems.
“When we think about social determinants of health, factors such as economic stability, access to transportation, and social and community context typically come to mind,” he said.
Piotr Orzechowski
, CEO and Co-Founder of Infermedica. “But language remains a fundamental barrier to care for many people in multicultural regions across the United States and the world. Health care can be daunting, frightening, and confusing, but regardless of the circumstances in which people are born, grow, live, work, and age, they should To be able to receive care in their native language.”
Infermedica’s platform, which includes the self-service symptom checker Symptomate, already helps more than 15 million users globally. This language expansion not only serves the needs of native speakers in various countries, but also supports expatriates and travelers who need medical guidance in their mother tongue. All Infermedica platform translations are done primarily by doctors in collaboration with trained linguists. This careful process ensures accurate delivery of the true meaning of medical terms across supported languages.
Furthermore, the Infermedica platform allows complete interviews to be conducted in one language with the option to automatically translate the results into any other supported language. This feature is especially useful for healthcare providers, caregivers or translators involved in patient care – enhancing communication and understanding between different healthcare stakeholders.
As part of its commitment to reducing barriers to accessing healthcare, Infermedica is also reviewing the use of plain language in all of its content. This initiative ensures that the language used in the main English version, from which translations are made, is as simple and understandable as possible.
As the world faces an increasing challenge in access to healthcare, with projections that by 2030 up to 5 billion people may lack access to basic healthcare, the Infermedica platform stands as a vital tool in bridging this gap. With long wait times for primary care appointments in various countries, platforms like Infermedica provide an immediate and accessible solution to prevent minor health issues from escalating into more serious ones.
About Enfirmedica
Infermedica is a global digital health leader specializing in AI-powered solutions for symptom analysis and patient triage. The company’s mission is to make healthcare accessible, accurate and convenient for everyone around the world, by automating primary care, from symptoms to outcomes. Infermedica is part of CB Insights’ Digital Health 150 – a list of the most promising private digital health companies. Since 2012, Infermedica has brilliantly integrated medical and technical expertise into medical technologies through its clinical guidance platform, supporting industry leaders including Allianz, Cigna, Microsoft, Médis and Solv. Infermedica is now used in over 30 countries in 24 languages and has completed over 15 million successful health screenings to date. To learn more, visit www.infermedica.com.
Media Contact:
Yancey Casey
Amendola Communications on behalf of Infermedica
(678) 895-9401
ycasey@acmarketingpr.com
View original content to download multimedia: https://www.prnewswire.com/news-releases/infermedica-expands-global-reach-with-support-for-24-languages-on-ai-powered-medical-guidance-platform -302013606.html
Nursing source
Infermedica, a leading provider of AI-powered clinical guidance, has recently announced the expansion of its global reach with support in 24 languages on its platform. This development marks a significant milestone for the company as it aims to make its innovative healthcare technology accessible to a broader and more diverse audience around the world. With this expansion, Infermedica seeks to revolutionize the way healthcare is delivered and improve access to accurate and efficient clinical guidance for patients and healthcare providers across different linguistic and cultural barriers.